Can Origanum be a hope for cancer treatment? A review on the potential of Origanum species in preventing and treating cancers.

Zuhal Emire, Erdal Yabalak

Journal: International journal of environmental health research 2023;33(9):894-910

PMID: 35414316

Abstract

In this study, the potential of aromatic Origanum species belonging to Lamiaceae family to prevent and treat cancer was investigated. Since aromatic plants contain phytochemicals such as essential oils, phenolic acids, terpenoids, flavonoids, alkaloids, vitamins, enzymes and minerals with beneficial biological activities, they have become more interesting and important in medicine, pharmacy and industry. Publications/research between 1950 and 2022 were screened to investigate the effects of Origanum species on cancer, and the effects of their extracts and essential oils in cancer prevention and treatment. Essential phytochemicals found in plants provide efficacy in the prevention and treatment of many diseases. Besides, the essential oils found in these plant extracts are another reason that makes them important. Therefore, it is preferred in traditional medicine in the fight against many diseases as well as cancer. Essential oils of Origanum species mainly contain monoterpenes such as -cymene, carvacrol, thymol and -terpinene. Since these compounds exhibit anticancer properties, Origanum species are becoming the plants of choice in the fight against cancer. In this context, majorana L. and munzurense are promising species, considering the composition of their extracts and essential oil.

Address: Faculty of Arts and Science, Department of Chemistry, Mersin University, Mersin, Turkey.; Department of Nanotechnology and Advanced Materials, Mersin University, Mersin, Turkey.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.